ACHV logo

Achieve Life Sciences (ACHV) Current Liabilities

Annual Current Liabilities

$20.81 M
-$786.00 K-3.64%

31 December 2023

ACHV Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Current Liabilities

$6.72 M
-$6.99 M-50.99%

30 September 2024

ACHV Quarterly Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ACHV Current Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-3.6%+64.5%
3 y3 years+609.1%+118.3%
5 y5 years+536.5%+114.0%

ACHV Current Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-3.6%+609.1%-68.9%+118.3%
5 y5 years-3.6%+625.4%-68.9%+335.0%
alltimeall time-32.4%+1636.4%-80.8%+538.9%

Achieve Life Sciences Current Liabilities History

DateAnnualQuarterly
Sept 2024
-
$6.72 M(-51.0%)
June 2024
-
$13.70 M(-33.4%)
Mar 2024
-
$20.57 M(-1.2%)
Dec 2023
$20.81 M(-3.6%)
$20.81 M(+409.9%)
Sept 2023
-
$4.08 M(+18.4%)
June 2023
-
$3.45 M(-83.0%)
Mar 2023
-
$20.30 M(-6.0%)
Dec 2022
$21.60 M(+374.7%)
$21.60 M(+212.3%)
Sept 2022
-
$6.92 M(+29.1%)
June 2022
-
$5.36 M(+33.6%)
Mar 2022
-
$4.01 M(-11.9%)
Dec 2021
$4.55 M(+55.0%)
$4.55 M(+47.9%)
Sept 2021
-
$3.08 M(-34.1%)
June 2021
-
$4.67 M(+32.9%)
Mar 2021
-
$3.52 M(+19.8%)
Dec 2020
$2.94 M(+2.3%)
$2.94 M(+58.8%)
Sept 2020
-
$1.85 M(+2.1%)
June 2020
-
$1.81 M(+17.2%)
Mar 2020
-
$1.54 M(-46.2%)
Dec 2019
$2.87 M(-12.3%)
$2.87 M(-8.6%)
Sept 2019
-
$3.14 M(+5.1%)
June 2019
-
$2.99 M(-25.3%)
Mar 2019
-
$4.00 M(+22.3%)
Dec 2018
$3.27 M(+62.4%)
$3.27 M(+10.4%)
Sept 2018
-
$2.96 M(+7.3%)
June 2018
-
$2.76 M(+19.1%)
Mar 2018
-
$2.32 M(+15.2%)
Dec 2017
$2.01 M(-34.5%)
$2.01 M(-13.6%)
Sept 2017
-
$2.33 M(+33.0%)
June 2017
-
$1.75 M(-11.5%)
Mar 2017
-
$1.98 M(-35.6%)
Dec 2016
$3.07 M(-85.1%)
$3.07 M(-71.0%)
Sept 2016
-
$10.59 M(-23.6%)
June 2016
-
$13.87 M(-4.6%)
Mar 2016
-
$14.53 M(-29.7%)
Dec 2015
$20.66 M(-7.0%)
$20.66 M(-29.6%)
Sept 2015
-
$29.35 M(-16.2%)
June 2015
-
$35.03 M(+115.8%)
Mar 2015
-
$16.24 M(-26.9%)
Dec 2014
$22.22 M(+48.8%)
$22.22 M(+6.2%)
Sept 2014
-
$20.93 M(+3.7%)
June 2014
-
$20.17 M(+19.4%)
Mar 2014
-
$16.90 M(+13.2%)
Dec 2013
$14.93 M(+29.2%)
$14.93 M(+3.9%)
Sept 2013
-
$14.37 M(+13.0%)
June 2013
-
$12.72 M(+15.6%)
Mar 2013
-
$11.00 M(-4.8%)
Dec 2012
$11.56 M(-62.5%)
$11.56 M(-46.7%)
Sept 2012
-
$21.67 M(-20.8%)
June 2012
-
$27.36 M(-11.6%)
Mar 2012
-
$30.95 M(+0.5%)
Dec 2011
$30.79 M(+12.0%)
$30.79 M(+61.0%)
Sept 2011
-
$19.12 M(-31.4%)
June 2011
-
$27.86 M(+8.8%)
Mar 2011
-
$25.61 M(-6.8%)
Dec 2010
$27.48 M(+6.6%)
$27.48 M(+104.0%)
Sept 2010
-
$13.47 M(+4.0%)
June 2010
-
$12.95 M(-28.6%)
Mar 2010
-
$18.13 M(-29.7%)
DateAnnualQuarterly
Dec 2009
$25.78 M(+793.9%)
$25.78 M(+1017.0%)
Sept 2009
-
$2.31 M(+5.4%)
June 2009
-
$2.19 M(+47.7%)
Mar 2009
-
$1.48 M(-48.6%)
Dec 2008
$2.88 M(-54.7%)
$2.88 M(-20.0%)
Sept 2008
-
$3.60 M(+67.0%)
June 2008
-
$2.16 M(-51.3%)
Mar 2008
-
$4.43 M(-30.4%)
Dec 2007
$6.37 M(-68.0%)
$6.37 M(-66.0%)
Sept 2007
-
$18.74 M(+28.7%)
June 2007
-
$14.56 M(-5.9%)
Mar 2007
-
$15.47 M(-22.3%)
Dec 2006
$19.91 M(+77.1%)
$19.91 M(+25.0%)
Sept 2006
-
$15.92 M(+9.9%)
June 2006
-
$14.49 M(+16.0%)
Mar 2006
-
$12.49 M(+11.1%)
Dec 2005
$11.24 M(+245.3%)
$11.24 M(+103.7%)
Sept 2005
-
$5.52 M(+141.5%)
June 2005
-
$2.29 M(+0.2%)
Mar 2005
-
$2.28 M(-29.9%)
Dec 2004
$3.26 M(+59.7%)
$3.26 M(+37.7%)
Sept 2004
-
$2.36 M(-6.0%)
June 2004
-
$2.51 M(+31.1%)
Mar 2004
-
$1.92 M(-5.9%)
Dec 2003
$2.04 M(+5.1%)
$2.04 M(-21.1%)
Sept 2003
-
$2.58 M(+8.8%)
June 2003
-
$2.38 M(+24.6%)
Mar 2003
-
$1.91 M(-1.7%)
Dec 2002
$1.94 M(+61.7%)
$1.94 M(-23.0%)
Sept 2002
-
$2.52 M(+16.7%)
June 2002
-
$2.16 M(+60.4%)
Mar 2002
-
$1.35 M(+12.3%)
Dec 2001
$1.20 M(-79.3%)
$1.20 M(+14.0%)
Sept 2001
-
$1.05 M(-53.2%)
June 2001
-
$2.25 M(-62.1%)
Mar 2001
-
$5.93 M(+2.2%)
Dec 2000
$5.80 M(-27.9%)
$5.80 M(-26.4%)
Sept 2000
-
$7.88 M(+0.9%)
June 2000
-
$7.81 M(-0.4%)
Mar 2000
-
$7.84 M(-2.5%)
Dec 1999
$8.04 M(-13.5%)
$8.04 M(-12.6%)
Sept 1999
-
$9.20 M(-1.1%)
June 1999
-
$9.30 M(+3.3%)
Mar 1999
-
$9.00 M(-3.2%)
Dec 1998
$9.30 M(-2.1%)
$9.30 M(-6.1%)
Sept 1998
-
$9.90 M(+5.3%)
June 1998
-
$9.40 M(+2.2%)
Mar 1998
-
$9.20 M(-3.2%)
Dec 1997
$9.50 M(-1.0%)
$9.50 M(-3.1%)
Sept 1997
-
$9.80 M(+3.2%)
June 1997
-
$9.50 M(+9.2%)
Mar 1997
-
$8.70 M(-9.4%)
Dec 1996
$9.60 M(+17.1%)
$9.60 M(+6.7%)
Sept 1996
-
$9.00 M(+3.4%)
June 1996
-
$8.70 M(-3.3%)
Mar 1996
-
$9.00 M(+9.8%)
Dec 1995
$8.20 M(-6.8%)
$8.20 M(-22.6%)
Sept 1995
-
$10.60 M(+20.5%)
Dec 1994
$8.80 M
$8.80 M

FAQ

  • What is Achieve Life Sciences annual total current liabilities?
  • What is the all time high annual current liabilities for Achieve Life Sciences?
  • What is Achieve Life Sciences annual current liabilities year-on-year change?
  • What is Achieve Life Sciences quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Achieve Life Sciences?
  • What is Achieve Life Sciences quarterly current liabilities year-on-year change?

What is Achieve Life Sciences annual total current liabilities?

The current annual current liabilities of ACHV is $20.81 M

What is the all time high annual current liabilities for Achieve Life Sciences?

Achieve Life Sciences all-time high annual total current liabilities is $30.79 M

What is Achieve Life Sciences annual current liabilities year-on-year change?

Over the past year, ACHV annual total current liabilities has changed by -$786.00 K (-3.64%)

What is Achieve Life Sciences quarterly total current liabilities?

The current quarterly current liabilities of ACHV is $6.72 M

What is the all time high quarterly current liabilities for Achieve Life Sciences?

Achieve Life Sciences all-time high quarterly total current liabilities is $35.03 M

What is Achieve Life Sciences quarterly current liabilities year-on-year change?

Over the past year, ACHV quarterly total current liabilities has changed by +$2.63 M (+64.53%)